KPT-9274
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KPT-9274, covering 2024-11-25 to 2026-01-27. Get the full timeline:
Most recent: Clinical Trial Update: KPT-9274 in Patients With Relapsed and Refractory Acute Myeloid Leukemia [Phase 1]